Schmulson Max J, Drossman Douglas A
Laboratorio de Hígado, Páncreas y Motilidad (HIPAM), Unidad de Investigación en Medicina Experimental, Facultad de Medicina-Universidad Nacional Autónoma de México (UNAM), Hospital General de México, Dr. Eduardo Liceaga, Mexico City, Mexico.
Center for Functional GI and Motility Disorders at University of North Carolina, USA.
J Neurogastroenterol Motil. 2017 Apr 30;23(2):151-163. doi: 10.5056/jnm16214.
Functional gastrointestinal disorders (FGIDs) are diagnosed and classified using the Rome criteria; the criteria may change over time as new scientific data emerge. The Rome IV was released in May 2016. The aim is to review the main changes in Rome IV. FGIDs are now called (). Rome IV has a multicultural rather than a Western-culture focus. There are new chapters including multicultural, age-gender-women's health, intestinal microenvironment, biopsychosocial, and centrally mediated disorders. New disorders have been included although not truly FGIDs, but fit the new definition of DGBI including , , and . Also, new FGIDs based on available evidence including and . Using a normative survey to determine the frequency of normal bowel symptoms in the general population changes in the time frame for diagnosis were introduced. For () only pain is required and discomfort was eliminated because it is non-specific, having different meanings in different languages. Pain is now related to bowel movements rather than just improving with bowel movements (ie, can get worse with bowel movement). Functional bowel disorders ( , , and ) are considered to be on a continuum rather than as independent entities. Clinical applications such as diagnostic algorithms and the Multidimensional Clinical Profile have been updated. The new Rome IV iteration is evidence-based, multicultural oriented and with clinical applications. As new evidence become available, future updates are expected.
功能性胃肠疾病(FGIDs)依据罗马标准进行诊断和分类;随着新科学数据的出现,这些标准可能会随时间而变化。罗马IV标准于2016年5月发布。目的是回顾罗马IV标准的主要变化。FGIDs现在被称为()。罗马IV标准关注多元文化而非西方文化。新增了包括多元文化、年龄-性别-女性健康、肠道微环境、生物心理社会以及中枢介导性疾病等章节。尽管并非真正的FGIDs,但符合功能性胃肠病新定义的新疾病已被纳入,包括()、()和()。此外,基于现有证据的新FGIDs包括()和()。采用规范性调查来确定普通人群正常肠道症状的频率,并引入了诊断时间框架的变化。对于(),仅需疼痛,不适被剔除,因为其不具有特异性,在不同语言中有不同含义。现在疼痛与排便相关,而非仅仅随着排便改善(即排便时可能加重)。功能性肠病(()、()、()和())被认为是一个连续统一体,而非独立的实体。诊断算法和多维临床概况等临床应用已得到更新。新的罗马IV版本以证据为基础,以多元文化为导向,并具有临床应用价值。随着新证据的出现,预计未来还会有更新。